Immutep’S Efti With Radiotherapy & KEYTRUDA® Meets Primary Endpoint In Phase 2 For Soft Tissue Sarcoma

RefinitivLess than 1 min read

Immutep Ltd IMM:

IMMUTEP’S EFTI WITH RADIOTHERAPY & KEYTRUDA® (PEMBROLIZUMAB) MEETS PRIMARY ENDPOINT IN PHASE II FOR SOFT TISSUE SARCOMA

© Copyright Thomson Reuters 2025. Click For Restrictions - https://agency.reuters.com/en/copyright.html

Login or create a forever free account to read this news